| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Tata Nifty MidSmall Healthcare Index Fund Reg (G) |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.05 |
| Equity |
99.94 |
| Trep |
0.11 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
41.21% |
| Top 10 Holdings |
61.21% |
| Top 25 Holdings |
94.07% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
62.76 |
| Healthcare |
37.18 |
| Cash |
0.06 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.89 |
| PE Ratio |
37.95 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Max Healthcare Institute Limited |
14.82 |
| Lupin Limited |
8.90 |
| Fortis Health Care Ltd |
6.62 |
| Aurobindo Pharma Limited |
5.90 |
| MANKIND PHARMA LIMITED |
4.97 |
| Alkem Laboratories Limited |
4.72 |
| Laurus Labs Limited |
4.36 |
| Glenmark Pharmaceuticals Limited |
4.22 |
| IPCA Laboratories Limited |
3.79 |
| Abbott India Limited |
2.91 |
| Krishna Inst of Medical Sciences Ltd. |
2.85 |
| Biocon Limited |
2.80 |
| Suven Pharmaceuticals Limited |
2.66 |
| Piramal Pharma Limited |
2.52 |
| Syngene International Limited |
2.50 |
| Gland Pharma Limited |
2.30 |
| Glaxosmithkline Pharma Ltd |
2.17 |
| J B Chemicals and Pharma Ltd |
2.12 |
| Narayana Hrudalaya Ltd |
2.09 |
| Ajanta Pharma Limited |
2.01 |
| Aster DM Healthcare Limited |
1.98 |
| EQ- GLOBAL HEALTH LTD. |
1.81 |
| Neuland Laboratories Limited |
1.81 |
| Dr Lal Path Labs Ltd |
1.68 |
| Poly Medicure Limited |
1.56 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
